← Open Payments lookup

SYDNEY VANGENNIP: Open Payments

NPI 1376252841 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$567 in 31 payments from 15 companies in 2025. Trend: 2023 $804 · 2024 $505 · 2025 $567

Food & beverage: $567
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.6$114
AstraZeneca Pharmaceuticals LP4$56
Lilly USA, LLC3$52
ABBVIE INC.3$52
Otsuka America Pharmaceutical, Inc.2$46
Novo Nordisk Inc2$40
Dexcom, Inc.2$37
Merck Sharp & Dohme LLC2$33
Janssen Pharmaceuticals, Inc1$27
Sumitomo Pharma America, Inc.1$22

Products named: JARDIANCE, BREZTRI, MOUNJARO, REXULTI, Dexcom G6 Transmitter, VRAYLAR, SPRAVATO, GEMTESA.

Industry payments across MO — which companies pay providers there.